« Previous
Next »
The Journal of Heart and Lung Transplantation
Volume 28, Issue 7
, Pages
670-675
, July 2009
Cytomegalovirus Prevention in High-risk Lung Transplant Recipients: Comparison of 3- vs 12-Month Valganciclovir Therapy
To access this article, please choose from the options below
PII: S1053-2498(09)00159-4
doi: 10.1016/j.healun.2009.03.012
© 2009 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Heart and Lung Transplantation
Volume 28, Issue 7
, Pages
670-675
, July 2009
